Cancer Biology

Targeting glutamine metabolism and redox state for leukemia therapy
Mark A. Gregory, Travis Nemkov, Vadym Zaberezhnyy, Hae J. Park, Sarah Gehrke, Kirk C. Hansen, Angelo D’Alessandro, James DeGregori

bioRxiv 303529; doi: https://doi.org/10.1101/303529

Add to Selected Citations
Intra-tumor heterogeneity defines treatment-resistant HER2+ breast tumors
Inga H. Rye, Anne Trinh, Anna Sætersdal, Daniel Nebdal, Ole Christian Lingjærde, Vanessa Almendro, Kornelia Polyak, Anne-Lise Børresen-Dale, Åslaug Helland, Florian Markowetz, Hege G. Russnes

bioRxiv 297549; doi: https://doi.org/10.1101/297549

Add to Selected Citations
Integrative analysis of DNA methylation suggests down-regulation of oncogenic pathways and reduced de-novo mutation in survival outliers of glioblastoma
Taeyoung Hwang, Dimitrios Mathios, Kerrie L McDonald, Irene Daris, Sung-Hye Park, Peter C Burger, Sojin Kim, Yun-Sik Dho, Hruban Carolyn, Chetan Bettegowda, Joo Heon Shin, Michael Lim, Chul-Kee Park

bioRxiv 302042; doi: https://doi.org/10.1101/302042

Add to Selected Citations
What does not kill a tumour may make it stronger: in silico Insights into Chemotherapeutic Drug Resistance
Sara Hamis, Perumal Nithiarasu, Gibin G Powathil

bioRxiv 230318; doi: https://doi.org/10.1101/230318 Confirmatory Results

Add to Selected Citations
Nonlinear dynamics of chemotherapeutic resistance
Y. Ma, P.K. Newton

bioRxiv 300582; doi: https://doi.org/10.1101/300582

Add to Selected Citations
A novel xenograft model reveals invasive mesenchymal transition and ineffective angiogenic response during anti-angiogenic therapy resistance
Arman Jahangiri, William Chen, Ankush Chandra, Alan Nguyen, Garima Yagnik, Jacob Weiss, Kayla J. Wolf, Jung-Ming G. Lin, Soeren Mueller, Jonathan Rick, Maxim Sidorov, Patrick Flanigan, W. Shawn Carbonell, Aaron Diaz, Luke Gilbert, Sanjay Kumar, Manish K. Aghi

bioRxiv 272328; doi: https://doi.org/10.1101/272328

Add to Selected Citations
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer Samples into Molecular Subtypes
Chanthirika Ragulan, Katherine Eason, Elisa Fontana, Gift Nyamundanda, Yatish Patil, Pawan Poudel, Rita T. Lawlor, Maguy Del Rio, Koo Si-Lin, Tan Wah Siew, Francesco Sclafani, Ruwaida Begum, Larissa S. Teixeira Mendes, Pierre Martineau, Aldo Scarpa, Iain Beehuat Tan, David Cunningham, Anguraj Sadanandam

bioRxiv 174847; doi: https://doi.org/10.1101/174847

Add to Selected Citations
The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease
Lindsay Kosack, Bettina Wingelhofer, Alexandra Popa, Bojan Vilagos, Anna Orlova, Peter Majek, Katja Parapatics, Alexander Lercher, Benedikt Agerer, Anna Ringler, Johanna Klughammer, Mark Smyth, Kseniya Khamina, Hatoon Baazim, David A. Rosa, Jisung Park, Patrick T. Gunning, Christoph Bock, Hannah V. Siddle, Stefan Kubicek, Elizabeth P. Murchison, Keiryn L. Bennett, Richard Moriggl, Andreas Bergthaler

bioRxiv 283309; doi: https://doi.org/10.1101/283309

Add to Selected Citations
Ras Suppresses TXNIP Expression by Restricting Ribosome Translocation
Zhizhou Ye, Donald E. Ayer

bioRxiv 299354; doi: https://doi.org/10.1101/299354

Add to Selected Citations
Aberrant splicing in B-cell acute lymphoblastic leukemia
Kathryn L. Black, Ammar S. Naqvi, Katharina E. Hayer, Scarlett Y. Yang, Elisabeth Gillespie, Asen Bagashev, Vinodh Pillai, Sarah K. Tasian, Matthew R. Gazzara, Martin Carroll, Deanne Taylor, Kristen W. Lynch, Yoseph Barash, Andrei Thomas-Tikhonenko

bioRxiv 225136; doi: https://doi.org/10.1101/225136

Add to Selected Citations

Cancer Biology

Pages